It was demonstrated that trans-stilbene was metabolically activated to the estrogenic compound by rat liver microsomes (Sugihara et al., Toxicol. Appl. Pharmacol., 167, 46-54 (2000)). In this study, determination of the isoforms of cytochrome P450 involved in the oxidation of the proestrogen, trans-stilbene, to its hydroxylated metabolites was examined. When trans-stilbene was incubated with rat liver microsomes in the presence of NADPH, estrogenic compounds, trans-4-hydroxystilbene and trans-4,4-dihydroxystilbene were formed. Comparison of the oxidase activity among liver microsomes of untreated, 3-methylcholanthrene-treated, acetone-treated, clofibrate-treated, dexamethasone-treated and phenobarbital-treated rats toward trans-stilbene showed that those from 3-methylcholanthrene-treated rats exhibited the highest activity. Human liver microsomes also catalyzed the oxidation in varying degrees. Variation in trans-stilbene oxidase activity was closely correlated to that of phenacetin O-deethylase activity. The oxidase activity was inhibited by a a-naphthoflavone; however, in this case trans-4,4-dihydroxystilbene was not detected. The oxidase activity toward trans-stilbene was exhibited by recombinant human cytochrome P450 1A1 and 1A2 expressed in a human B lymphoblastoid cell line.
trans-Stilbene is used as an industrial raw material for stilbene dyes and a fluorescent brightening agent. The trans-stilbene derivatives, diethylstilbestrol, euvestin, 4,4Ј-diaminostilbene and pinosylvin, have a variety of biological actions, including hormonal, hypocholesterolemic, sympathomimetic, antifungal, antiallergic, antibacterial, antimalarial and anticancer activities. [1] [2] [3] [4] [5] Diethylstilbestrol is the most famous stilbene derivative as a synthetic estrogen, and has been used medically as a substitute for endogenous estrogen, as hormonal therapy for prostate or breast cancer, and also to prevent threatened abortions. 6, 7) However, it may induce vaginal adenocarcinoma. 6, 8) Stilbene derivatives such as resveratrol (trans-4,3Ј,5Ј-trihydroxystilbene) are synthesized by stilbene synthase, which utilizes 3-malonyl-CoA and a starter CoA ester such as p-coumaroyl-CoA in plants. 9, 10) Some hydroxystilbenes and their oligomeric derivatives play an important role as stilbenoid phytoalexin, and are implicated in the process of induced resistance in some plants. 9) Resveratrol, which is found in grapes, peanuts and pines, and also in grape products such as wine, exerts potent antioxidant and anti-inflammatory activities.
11) Jang et al. 12) demonstrated that resveratrol inhibited the formation of tumor in mammary glands and skin in mice exposed to dimethylbenz[a]anthracene. Some reports also showed that resveratrol was an antagonist on aryl hydrocarbon receptor, and had estrogenic and antiestrogenic activities. [13] [14] [15] Recently, we examined the estrogenic activity of trans-stilbene using ERE-luciferase reporter assay in MCF-7 cells and estrogen responsive growth assay in MtT/E-2 cells. 16) In that study we showed that the compound was not estrogenic but exhibited a potent estrogenic activity after the metabolic activation by the liver microsomal oxidation system, and suggested that the estrogenic activity was due to the hydroxylated metabolites. 16) We did not however identify the cytochrome P450 (CYP) isoform. In the current study, the metabolism of trans-stilbene to the hydroxylated metabolites by liver microsomes of rats and humans was examined. CYP isoforms involving the oxidation were also examined using recombinant human CYP isoforms.
MATERIALS AND METHODS
Chemicals trans-Stilbene (98%) was obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan), cis-stilbene (Ͼ96%) from Nacalai Tesque, Inc. (Kyoto, Japan) and trans-4-hydroxystilbene (98%) from Lancaster Synthesis, Ltd. (Lancashire, England). trans-4,4Ј-Dihydroxystilbene (mp 275-278°C, 99% pure) was synthesized by the previously reported method. 16) Animals Male Sprague-Dawley rats (210-230 g) were obtained from Japan SLC, Inc. (Shizuoka, Japan). The animals were housed at 22°C with a 12-h light/dark cycle, with free access to tap water and a standard pellet diet MM-3 (Funabashi Farm, Funabashi, Japan). In some experiments, rats were intraperitoneally administered phenobarbital (80 mg/kg), dexamethasone (100 mg/kg), clofibrate (250 mg/kg) or 3-methylcholanthrene (25 mg/kg) daily for 3 d before use. Acetone was also orally administered to rats 14 h prior at a dose of 3 g/kg.
Preparation of Rat Liver Microsomes The livers were excised from exsanguinated rats and immediately perfused with 1.15% KCl. The livers were homogenized in four volumes of the KCl solution using a Potter-Elvehjem homogenizer. The microsomal fraction was obtained from the homogenate by successive centrifugation at 9000 g for 20 min and 105000 g for 60 min. The fraction was washed by resuspension in the KCl solution and resedimentation. The pellets of microsomes were resuspended in the solution to make 1 ml equivalent to 1 g of liver. Protein contents of liver microsomal preparation were determined by the method of Lowry et al.
17)
Human Liver Microsomes and Recombinant CYPs Human liver microsomes HG3, HG6, HG30 and HG89, and microsomal preparations from human B-lymphoblastoid cells expressed human CYP isoforms (i.e. CYP 1A1, 1A2, 2A6, 2B6, 2C9, 2D6, 2E1, 3A4 and 4A11) and baculovirus-in-fected insect cells expressed rat CYP 1A1 and 1A2, and antirat CYP 1A2 rabbit serum were purchased from Gentest Co. (Woburn, MA, U.S.A.).
Assay of Liver Microsomal Oxidase Activities toward trans-Stilbene An incubation mixture consisted of 0.1 mmol of trans-stilbene, 0.5 mmol of NADPH and 0.02 ml of liver microsomes equivalent to 20 mg liver wet weight (0.3-0.4 mg protein) or 50 ml (about 25 pmol CYP equivalent) of a CYP isoform in a final volume of 1 ml of 0.1 M K,Na-phosphate buffer (pH 7.4). The incubation was performed at 37°C for 20 min in the dark. After incubation, 0.1 ml of 2 N HCl and 0.1 mmol of phenothiazine as an internal standard were added and the mixture was extracted with 5 ml of diethyl ether. The extract was evaporated to dryness, the residue was dissolved in 0.1 ml of methanol, and an aliquot (5 ml) was analyzed by high-performance liquid chromatography (HPLC). Two metabolites of trans-stilbene isolated by HPLC were identified as trans-4-hydroxystilbene and trans-4,4Ј-dihydroxystilbene by mass and UV spectral comparison with authentic samples. The time courses of the hydroxylation of trans-stilbene to the hydroxyl derivatives were essentially linear for 20 min. The oxidase activity of the liver microsomes increased linearly with increasing amount of liver microsomes up to 25 ml (about 0.35 mg protein).
HPLC HPLC was performed in a Hitachi L-6000 chromatograph (Tokyo, Japan) fitted with a 250ϫ4.6 mm Shiseido Capcell Pak C18 type UG 120 Å 5-mm column (Shiseido Co., Ltd. Tokyo). The mobile phase was acetonitrilewater (1 : 1, v/v). The chromatograph was operated at a flow rate of 1.0 ml/min at a wavelength of 254 nm. The elution times of trans-4,4Ј-dihydroxystilbene, trans-4-hydroxystilbene, phenothiazine (an internal standard) and trans-stilbene were 5.5, 15.3, 22.2 and 56.5 min, respectively.
RESULTS AND DISCUSSION

Metabolism of trans-Stilbene by Rat Liver Microsomes
Liver microsomes of 3-methylcholanthrene-treated rats exhibited a significant oxidase activity toward trans-stilbene in the presence of NADPH. The amount of trans-4-hydroxystilbene (3.22 nmol/min/mg protein) formed was much higher than that of trans-4,4Ј-dihydroxystilbene (0.40 nmol/min/mg protein). The NADPH-linked activity was markedly inhibited by the addition of a-naphthoflavone (1ϫ10 Ϫ4 M). Furthermore, the activity was inhibited by the addition of anti-rat CYP 1A2 antibody, which also showed an immunoinhibitory effect on rat CYP 1A1. The oxidase activity was observed to only a small extent when liver microsomes of untreated, phenobarbital-treated, clofibrate-treated, acetone-treated or dexamethasone-treated rats were used instead of those of 3-methylcholanthrene-treated rats (Fig. 1) . The oxidation product was only trans-4-hydroxystilbene except in the case of 3-methylcholanthrene-treated rats. In untreated rats, the activity for the formation of trans-4-hydroxystilbene was 0.26 nmol/min/mg protein. Only marginal activity was observed when NADH was used instead of NADPH (data not shown). These facts suggest that trans-stilbene was mainly metabolized by CYP 1A1 or 1A2.
Oxidation of trans-Stilbene by Human Liver Microsomes Oxidase activity toward trans-stilbene was also examined using liver microsomes of four humans. The microsomes exhibited oxidase activity in the presence of NADPH in varying degrees. Variation of the activity in the four samples was closely correlated to phenacetin O-deethylase activity, which was exhibited by CYP 1A subfamily (Fig. 2) . In this case, trans-4,4Ј-dihydroxystilbene was not detected. The formation of trans-4-hydroxystilbene by the liver microsomes (HG30) was markedly inhibited by a-naphthoflavone, an inhibitor of CYP 1A1 and 1A2. These facts suggest that in humans the oxidation of trans-stilbene was mainly catalyzed by CYP 1A1/2, which are known major isoforms of CYP in humans. However, the activity of human liver was lower to some extent than the one of untreated rat liver.
Oxidation of trans-Stilbene by Recombinant CYP Isoforms The CYP isoforms involved in the oxidation of trans-stilbene to trans-4-hydroxystilbene was examined using the recombinant human CYP isoforms expressed in a human B lymphoblastoid cell line. The oxidation of transstilbene was mainly catalyzed by human CYP 1A1 and 1A2 isoforms. Human CYP 2D6 was also involved in the oxidation to some extent. However, CYP 2A6, 2B6, 2C9, 2E1, 3A4 or 4A11 did not have an appreciable ability to oxidize trans-stilbene. In this case, trans-4,4Ј-dihydroxystilbene was not detected in either case (Fig. 3) . Rat CYP 1A1 also exhib- ited the oxidase activity toward trans-stilbene. The amounts of trans-4-hydroxystilbene and trans-4,4Ј-dihydroxystilbene formed were 1.77 and 0.21 pmol/min/pmol P450, respectively. trans-Stilbene was also oxidized by rat CYP 1A2 to monohydroxy and dihydroxy derivatives at the rates of 1.28 and 0.03 pmol/min/pmol P450, respectively. In the experiments using rat CYP isoforms, trans-4,4Ј-dihydroxystilbene was detected with trans-4-hydroxystilbene. trans-4,4Ј-Dihydroxystilbene was not formed by the recombinant human CYP 1A1/2; this may have been due to the species difference of CYP 1A1/2. In contrast, cis-4-hydroxystilbene was not formed from cis-stilbene by incubation with CYP 1A1/2 (data not shown).
Metabolic Activation of trans-Stilbene In rats and rabbits in vivo, trans-4-hydroxystilbene, trans-4,4Ј-dihydroxystilbene, trans-3,4,4Ј-trihydroxystilbene and 4,4Ј-dihydroxydibenzyl have been found as urinary metabolites of trans-stilbene. [18] [19] [20] It was suggested that trans-stilbene is hydroxylated to trans-4-hydroxystilbene by liver enzymes, followed by double-bond reduction by intestinal bacteria. 21) In this study, we examined the oxidase system in rat and human liver microsomes, and obtained evidence that trans-stilbene was oxidized to the 4-hydroxyl derivative by CYP 1A1/2 isoforms.
We previously demonstrated that trans-stilbene is converted to an active estrogen by rat liver microsomal enzymes. 16) From the results of this study, a possible metabolic activation pathway of the proestrogen with liver microsomes is shown in Fig. 4 . trans-Stilbene is converted to hydroxylated derivatives by liver microsomes of rats and humans. In the microsomal system used in this study, the proestrogen, trans-stilbene, is mainly transformed to the estrogenic compound, trans-4-hydroxystilbene. The pathway of trans-4-hydroxystilbene to trans-4,4Ј-dihydroxystilbene does not proceed effectively in this system. In contrast, cis-stilbene was not metabolized to the corresponding hydroxylated metabolites with CYP 1A1/2 isoform. Thus, this is why cis-stilbene did not exhibit estrogenic activity after its metabolism by liver microsomes as shown earlier. 16) In conclusion, trans-stilbene was oxidized in rats and humans to trans-4-hydroxystilbene, an active metabolite for estrogen, by CYP 1A1/2. 
